EYECRO Trademark

Trademark Overview


On Friday, September 21, 2018, a trademark application was filed for EYECRO with the United States Patent and Trademark Office. The USPTO has given the EYECRO trademark a serial number of 88127331. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, September 23, 2025. This trademark is owned by EyeCRO, LLC. The EYECRO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields; Research in the field of Ophthalmology; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific...
eyecro

General Information


Serial Number88127331
Word MarkEYECRO
Filing DateFriday, September 21, 2018
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, September 23, 2025
Registration Number5792272
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements


Pseudo MarkEYE CRO
Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields; Research in the field of Ophthalmology; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Laboratory research services relating to pharmaceuticals; Medical research; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research; Scientific research and development; Technical research in the field of pharmaceutical studies; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 28, 2018
Primary Code042
First Use Anywhere DateWednesday, May 12, 2010
First Use In Commerce DateWednesday, May 12, 2010

Trademark Owner History


Party NameEyeCRO, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressOklahoma City, OK 73105

Party NameEyeCRO, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressOklahoma City, OK 73105

Party NameEyeCRO, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressOklahoma City, OK 73105

Trademark Events


Event DateEvent Description
Thursday, January 3, 2019NON-FINAL ACTION WRITTEN
Tuesday, September 25, 2018NEW APPLICATION ENTERED
Friday, September 28, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2019ASSIGNED TO EXAMINER
Thursday, January 3, 2019NON-FINAL ACTION E-MAILED
Thursday, January 3, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 10, 2019ASSIGNED TO LIE
Friday, January 18, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, January 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 30, 2019FINAL REFUSAL WRITTEN
Wednesday, January 30, 2019FINAL REFUSAL E-MAILED
Wednesday, January 30, 2019NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, March 7, 2019TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, March 11, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 11, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Friday, June 5, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 23, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Friday, August 25, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 13, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 14, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Friday, August 25, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, August 25, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, September 22, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 23, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 23, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, May 13, 2025TEAS SECTION 8 & 15 RECEIVED
Friday, August 25, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED